The -590C/T polymorphism in the IL-4 gene and the risk of cancer: A meta-analysis

Tumor Biology

Volumn 34, Issue 4, 2013, Pages 2261-2268

  Zhang, Jie ^a   Xie, Danli ^a   Zhou, Huaibin ^a   Fan, Runping ^a   Zhang, Longyi ^a   Li, Cixiu ^a   Jin, Sheng ^a   Meng, Qinghe ^a   Lu, Jianxin ^a  

^a BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

Author keywords

Cancer; Interleukin 4; Meta analysis; Polymorphism

Indexed keywords

INTERLEUKIN 4;

ARTICLE; ASIAN; BIBLIOGRAPHIC DATABASE; CANCER CLASSIFICATION; CANCER RISK; CANCER SUSCEPTIBILITY; CAUCASIAN; COLORECTAL CANCER; ETHNIC DIFFERENCE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HUMAN; INTERLEUKIN 4 GENE; MOLECULAR PATHOLOGY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; STOMACH CANCER;

EID: 84881481890     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-013-0767-2     Document Type: Article

References (38)

1. Krug EG, Mercy JA, Dahlberg LL, Zwi AB. The world report on violence and health. Lancet. 2002;360:1083-8.
2. Arjumand W, Ahmad ST, Seth A, Saini AK, Sultana S. Vitamin d receptor foki and bsmi gene polymorphism and its association with grade and stage of renal cell carcinoma in north Indian population. Tumor Biol. 2012;33:23-31.
3. Hoover RN. Cancer - nature, nurture, or both. New Engl J Med. 2000;343:135-6.
4. Ponder BAJ. Cancer genetics. Nature. 2001;411:336-41.
5. Ernst A, Hofmann S, Ahmadi R, Becker N, Korshunov A, Engel F, et al. Genomic and expression profiling of glioblastoma stem cell-like spheroid cultures identifies novel tumor-relevant genes associated with survival. Clin Cancer Res. 2009;15:6541-50.
6. Cui L, Dillehay K, Chen W, Shen D, Dong Z, Li W. Association of the cyp1b1 leu432val polymorphism with the risk of prostate cancer: a meta-analysis. Mol Biol Rep. 2012;39:7465-71.
7. Jiang J, Liang X, Zhou X, Huang R, Chu Z, Zhan Q. Ercc1 expression as a prognostic and predictive factor in patients with non-small cell lung cancer: a meta-analysis. Mol Biol Rep. 2012;39:6933-42.
8. Zou JH, An L, Chen S, Ren LQ. Xpa a23g polymorphism and lung cancer risk: a meta-analysis. Mol Biol Rep. 2012;39:1435-40.
9. Zhou L, Yao F, Luan H, Wang Y, Dong X, Zhou W, Wang Q. Cyp3a4*1b polymorphism and cancer risk: a huge review and meta-analysis. Tumor Biol. 2012;34:649-660.
10. Xiao X, Wang X, Zang D. Mmp1-1607 1g/2g polymorphism and lung cancer risk: a meta-analysis. Tumor Biol. 2012;33:2385-92.
11. Aggarwal BB, Vijayalekshmi RV, Sung B. Targeting inflammatory pathways for prevention and therapy of cancer: short-term friend, long-term foe. Clin Cancer Res. 2009;15:425-30.
12. Cozar JM, Romero JM, Aptsiauri N, Vazquez F, Vilchez JR, Tallada M, et al. High incidence of CTLA-4 AA (CT60) polymorphism in renal cell cancer. Hum Immunol. 2007;68:698-704.
13. García-González MA, Lanas A, Quintero E, Nicolás D, Parra-Blanco A, Strunk M, et al. Gastric cancer susceptibility is not linked to pro-and anti-inflammatory cytokine gene polymorphisms in whites: a nationwide multicenter study in Spain. Am J Gastroenterol. 2007;102:1878-92.
14. Gaur P, Mittal M, Mohanti BK, Das SN. Functional variants of il4 and il6 genes and risk of tobacco-related oral carcinoma in high-risk Asian Indians. Oral Dis. 2011;17:720-6.
15. Lai KC, Chen WC, Jeng LB, Li SY, Chou MC, Tsai FJ. Association of genetic polymorphisms of MK, IL-4, p16, p21, p53 genes and human gastric cancer in Taiwan. Eur J Surg Oncol. 2005;31:1135-40.
16. Landi S, Bottari F, Gemignani F, Gioia-Patricola L, Guino E, Osorio A, et al. Interleukin-4 and interleukin-4 receptor polymorphisms and colorectal cancer risk. Eur J Cancer. 2007;43:762-8.
17. Crusius J, Canzian F, Capellá G, Peña AS, Pera G, Sala N, et al. Cytokine gene polymorphisms and the risk of adenocarcinoma of the stomach in the European prospective investigation into cancer and nutrition (EPIC-EURGAST). Ann Oncol. 2008;19:1894-902.
18. Howell WM, Turner SJ, Theaker JM, Bateman AC. Cytokine gene single nucleotide polymorphisms and susceptibility to and prognosis in cutaneous malignant melanoma. Eur J Immunogenet. 2003;30:409-14.
19. Liang XL, Hu HB, Jia AP, Liu ZP. Association of ptpn11 and interleukin-4 gene poolymorphisms and helicobacter pylori infection with susceptibility to gastric cancer (Chinese). Hai Nan Yi Xue. 2010;21:1-5.
20. Chu H, Wang M, Yan F, Zhong D, Shi D, Ma L, et al. Polymorphisms in the IL-13 and IL-4r genes are associated with the development of renal cell carcinoma. Ann Oncol. 2012;23:2114-21.
21. Schonfeld SJ, Bhatti P, Brown EE, Linet MS, Simon SL, Weinstock RM, et al. Polymorphisms in oxidative stress and inflammation pathway genes, low-dose ionizing radiation, and the risk of breast cancer among us radiologic technologists. Cancer Causes and Control. 2010;21:1857-66.
22. Suchy J, Kłujszo-Grabowska E, Kładny J, Cybulski C, Wokołorczyk D, Szymańska-Pasternak J, et al. Inflammatory response gene polymorphisms and their relationship with colorectal cancer risk. BMC Cancer. 2008;8:112.
23. Welsh MM, Karagas MR, Kuriger JK, Houseman A, Spencer SK, Perry AE, et al. Genetic determinants of UV-susceptibility in non-melanoma skin cancer. PLoS One. 2011;6:e20019.
24. Chu H, Ma L, Wang M, Shi D, Qin C, Yuan L, et al. The polymorphisms of IL-4, IL-4r and IL-13 genes and bladder cancer risk in a Chinese population: a case-control study. Mol Biol Rep. 2012;39:5349-57.
25. Ando T, Ishikawa T, Kato H, Yoshida N, Naito Y, Kokura S, et al. Synergistic effect of HLA class II loci and cytokine gene polymorphisms on the risk of gastric cancer in Japanese patients with Helicobacter pylori infection. Int J Cancer. 2009;125:2595-602.
26. Andrie E, Michos A, Kalampoki V, Pourtsidis A, Moschovi M, Polychronopoulou S, et al. Genetic variants in immunoregulatory genes and risk for childhood lymphomas. Eur J Haematol. 2009;83:334-42.
27. Zhang YG, Li XB, Zhang J, Huang J, He C, Tian C, et al. The I/D polymorphism of angiotensin-converting enzyme gene and asthma risk: a meta-analysis. Allergy. 2011;66:197-205.
28. Zhong X, Hui C, Xiao-Ling W, Yan L, Na L. Nat2 polymorphism and gastric cancer susceptibility: a meta-analysis. Arch Med Res. 2010;41:275-80.
29. Bhayal AC, Prabhakar B, Rao KPR, Penchikala A, Ayesha Q, Jyothy A, et al. Role of transforming growth factor-β1-509 C/T promoter polymorphism in gastric cancer in south Indian population. Tumor Biol. 2011;32:1049-53.
30. Lin XH. Correlation of interleukin 4-590 and intron 3 polymorphisms to genetic susceptibility to gastric cardiac carcinoma and noncardiac gastric carcinoma (Chinese), 2008. http://d.wanfangdata.com.cn/Thesis-Y1333908.aspx
31. Purdue MP, Sakoda LC, Graubard BI, Welch R, Chanock SJ, Sesterhenn IA, et al. A case-control investigation of immune function gene polymorphisms and risk of testicular germ cell tumors. Cancer Epidem Biomar. 2007;16:77-83.
32. Rizzato C, Canzian F, Rudnai P, Gurzau E, Stein A, Koppova K, et al. Interaction between functional polymorphic variants in cytokine genes, established risk factors and susceptibility to basal cell carcinoma of skin. Carcinogenesis. 2011;32:1849-54.
33. Tsai MH, Chen WC, Tsai CH, Hang LW, Tsai FJ. Interleukin-4 gene, but not the interleukin-1 beta gene polymorphism, is associated with oral cancer. J Clin Lab Anal. 2005;19:93-8.
34. Wiemels JL, Wiencke JK, Kelsey KT, Moghadassi M, Rice T, Urayama KY, et al. Allergy-related polymorphisms influence glioma status and serum IgE levels. Cancer Epidemiol Biomarkers Prev. 2007;16:1229-35.
35. Wilkening S, Tavelin B, Canzian F, Enquist K, Palmqvist R, Altieri A, et al. Interleukin promoter polymorphisms and prognosis in colorectal cancer. Carcinogenesis. 2008;29:1202-6.
36. Zambon CF, Basso D, Marchet A, Fasolo M, Stranges A, Schiavon S, et al. IL-4-588C>T polymorphism and IL-4 receptor alpha [Ex5 + 14A>G; Ex11 + 828A>G] haplotype concur in selecting H. pylori cagA subtype infections. Clin Chim Acta. 2008;389:139-45.
37. Zhou SZ. The study on the relationship between cytokine gene polymorphisms and gastric cancer in Chinese (Chinese), 2005. http://d.wanfangdata.com.cn/Thesis-Y768159.aspx
38. Guo-Qing P, Yuan Y, Cai-Gao Z, Hongling Y, Gonghua H, Yan T. A study of association between expression of hOGG1, VDAC1, HK-2 and cervical carcinoma. J Exp Clin Canc Res. 2010;29:129.